LSL Pharma Group Inc (TSE:LSL) has released an update.
LSL Pharma Group Inc. has announced a strategic acquisition of a Quebec-based competitor for $2.5 million, which is expected to increase their annual revenues by 15-20% and enhance overall profitability. The deal, slated to close by the end of Q2-2024, will also expand LSL’s presence in the natural health products sector and is anticipated to create significant synergies within their existing operations. The acquisition is financed through recent private placements and includes a fully operational manufacturing plant.
For further insights into TSE:LSL stock, check out TipRanks’ Stock Analysis page.
